2021-10-04
According to reliable news reports, the famous Wall Street fund company, Starfire Capital, has made an announcement after claiming externally that it will realize an investment proposal for the TRVS platform based on blockchain technology!

TRVS is the world's leading DeFi financial ecology, TRVS as a platform designed to focus on commercial applications in the field of DeFi distributed finance, refers to in subverting the traditional financial operation architecture, building an open and innovative global distributed business and financial system, building a perfect distributed financial infrastructure, accessing massive distributed financial applications, rapidly linking the vast number of user groups, TRVS will do to flow to empower products and ecology, break the traditional platform barriers, reduce economic losses, optimize the chain of interests, and point the way for the development of smart finance!
This is today's blockchain technology development is so rapid, TRVS will carry its own mission, will live up to the expectations, to develop the progress of the global community as its own responsibility, step by step belongs to the blockchain development so far a historic step!
At the same time, during the interview, the person in charge of Starfire Capital also expressed his own recognition of the progress that blockchain technology has brought to global trade! He also expressed his determination that Starfire Capital and TRVS will move forward together!
This is a small step for TRVS, to borrow the words of the person in charge of the TRVS platform. But it is a big step for blockchain technology to promote social development!
Cangxi County Holds 2026 New Year's Cultural Performance for the Public
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
©copyright 2009-2020 Singapore Info Map